SAN DIEGO, Aug. 22 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Kevin O'Boyle, Executive Vice President and Chief Financial Officer, is scheduled to present at the Thomas Weisel Partners Healthcare Conference at the Four Season Hotel, Boston, MA, on Thursday, September 6, 2007, at 9:45 a.m. ET.
A live Web cast of the presentation will be available online from the investor relations page of the Company's corporate Web site at http://www.nuvasive.com. After the live Web cast, the presentation will remain available on NuVasive's Web site, http://www.nuvasive.com, for 30 days.
NuVasive is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused on applications in the over $3.6 billion U.S. spine fusion market. The Company's current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS(TM), as well as a growing offering of cervical and motion preservation products.
The MAS platform offers advantages for both patients and surgeons such
as reduced surgery and hospitalization time and faster recovery. MAS
combines three categories of current product offerings: NeuroVision(R) a
proprietary software-driven nerve avoidance system; MaXcess(R) a unique
split-blade design retraction system; and specialized implants, like
SpheRx(R) and CoRoent(R), that collectively minimize soft tissue disruption
during spine surgery while allowing maximum visualization and surgical
reproducibility. NuVasive's product offering is also focused on cervical
internal fixation products and its R&D pipeline emphasizes both MAS and
|SOURCE NuVasive, Inc.|
Copyright©2007 PR Newswire.
All rights reserved